Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1993;13:1680-1688

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koivisto, P. V.
Right arrow Articles by Kontula, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koivisto, P. V.
Right arrow Articles by Kontula, K.

Arteriosclerosis and Thrombosis, Vol 13, 1680-1688, Copyright © 1993 by American Heart Association


ARTICLES

Deletion of exon 15 of the LDL receptor gene is associated with a mild form of familial hypercholesterolemia. FH-Espoo

PV Koivisto, UM Koivisto, PT Kovanen, H Gylling, TA Miettinen and K Kontula
Second Department of Medicine, University of Helsinki, Finland.

We describe a mutation of the low-density lipoprotein (LDL) receptor gene, designated familial hypercholesterolemia (FH)-Espoo, which deletes exon 15 of the LDL receptor gene. The mutant receptor is predicted to lack 57 amino acids, including 18 serine and threonine residues, which are the sites of the clustered O-linked sugars of the receptor. Studies on 10 carriers of this gene revealed that FH-Espoo is associated with an exceptionally mild form of FH. Thus, in conditions in which cell proliferation was rendered dependent on the function of LDL receptors, lymphocytes from the patients with the FH-Espoo allele had a growth rate intermediate between those from healthy subjects and patients with the FH-Helsinki gene, a mutation known to abolish LDL receptor function. The in vivo fractional catabolic rate of LDL apolipoprotein B was lower than normal in the two FH-Espoo heterozygotes studied. Although higher than those in healthy controls, the serum LDL cholesterol concentrations in patients with the FH-Espoo gene were significantly lower than those in patients with the FH- Helsinki mutation. The thickness of the Achilles tendons was within the normal limits in subjects with the FH-Espoo gene. Our study suggests that moderate varieties of hypercholesterolemia, ie, those not considered to represent FH, may occasionally be due to subtle LDL receptor gene mutations.


This article has been cited by other articles:


Home page
Am J EpidemiolHome page
M. A. Austin, C. M. Hutter, R. L. Zimmern, and S. E. Humphries
Familial Hypercholesterolemia and Coronary Heart Disease: A HuGE Association Review
Am. J. Epidemiol., September 1, 2004; 160(5): 421 - 429.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
K. E HEATH, R. A WHITTALL, G. J MILLER, and S. E HUMPHRIES
I705 variant in the low density lipoprotein receptor gene has no effect on plasma cholesterol levels
J. Med. Genet., September 1, 2000; 37(9): 713 - 715.
[Full Text]


Home page
J. Med. Genet.Home page
K. E Heath, I. N M Day, and S. E Humphries
Universal primer quantitative fluorescent multiplex (UPQFM) PCR: a method to detect major and minor rearrangements of the low density lipoprotein receptor gene
J. Med. Genet., April 1, 2000; 37(4): 272 - 280.
[Abstract] [Full Text]


Home page
J. Lipid Res.Home page
L. Haddad, I. N. M. Day, S. Hunt, R. R. Williams, S. E. Humphries, and P. N. Hopkins
Evidence for a third genetic locus causing familial hypercholesterolemia: a non-LDLR, non-APOB kindred
J. Lipid Res., June 1, 1999; 40(6): 1113 - 1122.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
X.-M. Sun, D. D. Patel, B. L. Knight, and A. K. Soutar
Comparison of the Genetic Defect with LDL-Receptor Activity in Cultured Cells from Patients With a Clinical Diagnosis of Heterozygous Familial Hypercholesterolemia
Arterioscler Thromb Vasc Biol, November 1, 1997; 17(11): 3092 - 3101.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. F. Vuorio, H. Turtola, and K. Kontula
Neonatal Diagnosis of Familial Hypercholesterolemia in Newborns Born to a Parent With a Molecularly Defined Heterozygous Familial Hypercholesterolemia
Arterioscler Thromb Vasc Biol, November 1, 1997; 17(11): 3332 - 3337.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
U.-M. Koivisto, H. Gylling, T. A. Miettinen, and K. Kontula
Familial Moderate Hypercholesterolemia Caused by Asp235->Glu Mutation of the LDL Receptor Gene and Co-occurrence of a De Novo Deletion of the LDL Receptor Gene in the Same Family
Arterioscler Thromb Vasc Biol, July 1, 1997; 17(7): 1392 - 1399.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
H. Bujo, K. A. Lindstedt, M. Hermann, L. M. Dalmau, J. Nimpf, and W. J. Schneider
Chicken Oocytes and Somatic Cells Express Different Splice Variants of a Multifunctional Receptor
J. Biol. Chem., October 6, 1995; 270(40): 23546 - 23551.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Ferrieres, J. Lambert, S. Lussier-Cacan, and J. Davignon
Coronary Artery Disease in Heterozygous Familial Hypercholesterolemia Patients With the Same LDL Receptor Gene Mutation
Circulation, August 1, 1995; 92(3): 290 - 295.
[Abstract] [Full Text]


Home page
CirculationHome page
H. Nissen, A. B. Hansen, P. Guldberg, N. E. Petersen, M. L. Larsen, T. Haghfelt, K. Kristiansen, and M. Horder
Genetic Diagnosis With the Denaturing Gradient Gel Electrophoresis Technique Improves Diagnostic Precision in Familial Hypercholesterolemia
Circulation, March 15, 1995; 91(6): 1641 - 1646.
[Abstract] [Full Text]